Literature DB >> 7752093

Felbamate block of the N-methyl-D-aspartate receptor.

S Subramaniam1, J M Rho, L Penix, S D Donevan, R P Fielding, M A Rogawski.   

Abstract

The anticonvulsant felbamate may act as an N-methyl-D-aspartate (NMDA) receptor antagonist, but the mechanism of block has not been fully characterized. We sought to identify the sites at which felbamate exerts its NMDA receptor blocking action using radioligand binding to rat forebrain membranes and whole-cell voltage clamp and single-channel recordings from cultured rat hippocampal neurons. Equilibrium binding isotherms for [3H]dizocilpine, a channel blocking ligand, were obtained in the presence of saturating glutamate and glycine. At a concentration of 1 mM, felbamate competitively inhibited specific [3H]dizocilpine binding, indicating that felbamate interacts with the channel blocking site. At a higher concentration (3 mM), felbamate also reduced the maximal saturation binding, demonstrating an additional allosteric action. The dissociation constant (Kb), estimated from fits to the binding isotherms, was 0.7-1.1 mM. It has been proposed that felbamate block of NMDA receptors occurs via competitive glycine site antagonism. However, the slowing of [3H]dizocilpine dissociation by felbamate, unlike the slowing produced by 7-chlorokynurenic acid, was not reversed by increasing the glycine concentration. In addition, felbamate did not reduce specific binding of [3H]5,7-dichlorokynurenic acid, a glycine site ligand. In whole-cell voltage clamp recordings of NMDA receptor currents, its blocking time constant (69 +/- 0.4 msec) was substantially faster than the dissociation time constant of glycine (390 +/- 23 msec), whereas the time constant for 5,7-dichlorokynurenic acid (390 +/- 20 msec) was similar. These observations indicate that felbamate block of NMDA receptors does not occur by an action at the glycine site.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7752093

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  13 in total

Review 1.  Diverse mechanisms of antiepileptic drugs in the development pipeline.

Authors:  Michael A Rogawski
Journal:  Epilepsy Res       Date:  2006-04-18       Impact factor: 3.045

Review 2.  Molecular targets for antiepileptic drug development.

Authors:  Brian S Meldrum; Michael A Rogawski
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

3.  Phytochemical screening and anticonvulsant studies of ethyl acetate fraction of Globimetula braunii on laboratory animals.

Authors:  Musa Mumammad Aliyu; Abdullahi Isma'il Musa; Muhammad Ja'afar Kamal; Magaji Garba Mohammed
Journal:  Asian Pac J Trop Biomed       Date:  2014-04

4.  Anticonvulsant and anxiolytic-like effects of compounds isolated from Polygala sabulosa (Polygalaceae) in rodents: in vitro and in vivo interactions with benzodiazepine binding sites.

Authors:  Filipe Silveira Duarte; Mariel Marder; Alexandre Ademar Hoeller; Marcelo Duzzioni; Beatriz Garcia Mendes; Moacir Geraldo Pizzolatti; Thereza Christina Monteiro De Lima
Journal:  Psychopharmacology (Berl)       Date:  2007-12-22       Impact factor: 4.530

5.  The novel antiepileptic drug carisbamate (RWJ 333369) is effective in inhibiting spontaneous recurrent seizure discharges and blocking sustained repetitive firing in cultured hippocampal neurons.

Authors:  Laxmikant S Deshpande; Nisha Nagarkatti; Sompong Sombati; Robert J DeLorenzo
Journal:  Epilepsy Res       Date:  2008-03-18       Impact factor: 3.045

6.  Anticonvulsant effect of felbamate in the pentylenetetrazole kindling model of epilepsy in the rat.

Authors:  O Giorgi; G Carboni; V Frau; M Orlandi; V Valentini; A Feldman; M G Corda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-07       Impact factor: 3.000

Review 7.  Molecular mechanisms of antiseizure drug activity at GABAA receptors.

Authors:  L John Greenfield
Journal:  Seizure       Date:  2013-05-14       Impact factor: 3.184

8.  Characterization of the gating conformational changes in the felbamate binding site in NMDA channels.

Authors:  Huai-Ren Chang; Chung-Chin Kuo
Journal:  Biophys J       Date:  2007-04-27       Impact factor: 4.033

Review 9.  NMDA receptors in clinical neurology: excitatory times ahead.

Authors:  Lorraine V Kalia; Suneil K Kalia; Michael W Salter
Journal:  Lancet Neurol       Date:  2008-08       Impact factor: 44.182

10.  Extracellular proton-modulated pore-blocking effect of the anticonvulsant felbamate on NMDA channels.

Authors:  Huai-Ren Chang; Chung-Chin Kuo
Journal:  Biophys J       Date:  2007-05-18       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.